Skip to main content
. 2020 Nov 3;9(11):2409. doi: 10.3390/cells9112409

Figure 8.

Figure 8

Evaluation of rRNA expression and the effect of low-dose Actinomycin D (50 ng/mL, 2 h) treatment in lung adenocarcinoma cell lines. (A) 47/45S precursor ribosomal RNA (pre-rRNA) and (B) 28S mature rRNA. Relative transcription level of untreated H1650 cells was assumed as 1. n.s., not significant; * p < 0.05; ** p < 0.01.